[Role of echocardiography in the detection and the monitoring of left ventricular systolic dysfunction in patients undergoing cancer therapy].
Ann Cardiol Angeiol (Paris). 2020 Sep 19;:
Authors: Charbonnel C
Cardio-oncology has recently been developed to prevent, identify and manage cardiovascular events in patients with cancer receiving cardiotoxic chemotherapy. Among cardiovascular complications of cancer therapy, myocardial dysfunction and heart failure are one of the most concerning issue. Since cardiotoxicity adversely affect quality of life and prognosis in cancer patients, its prevention, detection and treatment are crucial. This review aimed to describe the main chemotherapies able to induce myocardial dysfunction and to emphazise the pivotal role of echocardiography in the follow up. We also intent to provide to the lector a better understanding of what to do in case of cardiotoxicity.
PMID: 32962803 [PubMed – as supplied by publisher]